-
Pushed to margins, women vanish from Bangladesh's political arena
-
Crypto firm accidentally sends $40 bn in bitcoin to users
-
Pistons end Knicks' NBA winning streak, Celtics edge Heat
-
Funerals for victims of suicide blast at Islamabad mosque that killed at least 31
-
A tale of two villages: Cambodians lament Thailand's border gains
-
Police identify suspect in disappearance of Australian boy
-
Cuba adopts urgent measures to address energy crisis: minister
-
Not-so-American football: the Super Bowl's overseas stars
-
Trump says US talks with Iran 'very good,' more negotiations expected
-
Trump administration re-approves twice-banned pesticide
-
Hisatsune leads Matsuyama at Phoenix Open as Scheffler makes cut
-
Beyond the QBs: 5 Super Bowl players to watch
-
Grass v artificial turf: Super Bowl players speak out
-
Police warn Sydney protesters ahead of Israeli president's visit
-
Bolivia wants closer US ties, without alienating China: minister
-
Ex-MLB outfielder Puig guilty in federal sports betting case
-
Milan-Cortina Winter Olympics open with dazzling ceremony
-
China overturns death sentence for Canadian in drug case
-
Trump reinstates commercial fishing in protected Atlantic waters
-
Man Utd can't rush manager choice: Carrick
-
Leeds boost survival bid with win over relegation rivals Forest
-
Stars, Clydesdales and an AI beef jostle for Super Bowl ad glory
-
Dow surges above 50,000 for first time as US stocks regain mojo
-
Freeski star Gu says injuries hit confidence as she targets Olympic treble
-
UK police search properties in Mandelson probe
-
Bompastor extends contract as Chelsea Women's boss despite slump
-
Milan-Cortina Winter Olympics open with glittering ceremony
-
A French yoga teacher's 'hell' in a Venezuelan jail
-
England's Underhill taking nothing for granted against Wales
-
Fans cheer for absent Ronaldo as Saudi row deepens
-
Violence-ridden Haiti in limbo as transitional council wraps up
-
Hundreds protest in Milan ahead of Winter Olympics
-
Suspect in murder of Colombian footballer Escobar killed in Mexico
-
Wainwright says England game still 'huge occasion' despite Welsh woes
-
WADA shrugs off USA withholding dues
-
Winter Olympics to open with star-studded ceremony
-
Trump posts, then deletes, racist clip of Obamas as monkeys
-
Danone expands recall of infant formula batches in Europe
-
Trump deletes racist video post of Obamas as monkeys
-
Colombia's Rodriguez signs with MLS side Minnesota United
-
UK police probing Mandelson after Epstein revelations search properties
-
Russian drone hits Ukrainian animal shelter
-
US says new nuclear deal should include China, accuses Beijing of secret tests
-
French cycling hope Seixas dreaming of Tour de France debut
-
France detects Russia-linked Epstein smear attempt against Macron: govt source
-
EU nations back chemical recycling for plastic bottles
-
Iran expects more US talks after 'positive atmosphere' in Oman
-
US says 'key participant' in 2012 attack on Benghazi mission arrested
-
Why bitcoin is losing its luster after stratospheric rise
-
Arteta apologises to Rosenior after disrespect row
US overdose capital Baltimore on long road to recovery
Carrying a bag filled with the overdose-reversing drug naloxone, Adam Trionfo roams the brick-lined streets of one of America's oldest port cities, Baltimore.
The 40-year-old and his small team visit neighborhoods considered "hot spots" for drug trafficking to hand out the precious antidote, sold under the brand name Narcan.
The easy-to-use nasal spray has become a key tool in the fight against the deadly US opioid crisis, claiming 750,000 lives between the late 1990s and 2022.
"Just over the past week, we distributed 200 Narcan kits," Trionfo, who oversees an addiction assistance program with the local branch of Catholic Charities, told AFP.
On their route, the team spots a man sprawled out amid a pile of rubbish in the corner of a stairwell. They hand him a box of Narcan and a brochure about their organization.
The man takes it with one hand, as he awkwardly hides a syringe behind his back.
Their last Narcan kit goes to another man, legs covered in brown scars, who is waiting near a dilapidated building.
These scenes are not uncommon in this East Coast city, which is located about 50 kilometers (31 miles) from Washington and is renowned for endemic crime.
Baltimore was the setting of the hit television series "The Wire" in the early 2000s, depicting its burgeoning drug scene from a variety of angles.
And last year, the New York Times dubbed the city the "American overdose capital."
Between 2018 and 2022, the drug-related mortality rate was nearly twice as high as in any other major American city. The leading killer: fentanyl.
- 'Tremendous efforts' -
Since the height of the opioid crisis in 2021, the outlook has improved in much of the country, including in Baltimore.
The number of fatal overdoses in the city plummeted by 35 percent last year, to 680 down from 1,043 in 2023.
The city's proactive policies, coupled with preventative work done by Catholic charities in Baltimore's communities have helped make a dent in the problem.
"We've had tremendous efforts throughout the city to get people into treatment, and then we've also had tremendous efforts in getting Naloxone out there," said Michael Fingerhood, head of addiction medicine at Johns Hopkins Bayview Medical Center.
Distributed broadly for about a decade, Narcan has worked like a "fire extinguisher," Fingerhood said.
In Baltimore, Narcan is now available everywhere: pharmacies, vending machines throughout the city, even in libraries.
- Funded by restitution -
The drop in mortality in Baltimore is also linked to the composition of the fentanyl being sold there, Fingerhood said.
"The drug supply has less potent fentanyl and has additives that are less likely to cause overdose."
Awareness of the risks associated with the powerful synthetic opioid has also grown among users, pushing them to be more "cautious," said Bakari Atiba, community engagement director at Charm City Care Connection.
The nonprofit assists addicts in Baltimore -- known as Charm City -- and recently received funding from a restitution program fueled by lawsuits against opioid manufacturers and distributors.
"I'm not saying people are going to stop using," Atiba said. "That's not even our goal."
"It's about meeting people where they are, making sure they're safe, making sure they're supported, and making sure they have pathways to recovery if they want it."
A.P.Maia--PC